Vialwirebiotech, curated
July 3, 2026, 3:38 PM
May 22, 2026
- 2:35 PM · Endpoints News2:35 PMFDA clears Gilead's hepatitis D drug, four years after prior rejection — Endpoints News
- 1:50 PM · Endpoints News1:50 PMGOP lawmaker asks Trump administration to curb China biotech deals — Endpoints News
- 12:00 PM · BioWorld12:00 PMDaewoong takes over Turn Bio’s longevity platform from Hanall — BioWorld
- 12:00 PM · BioWorld12:00 PMEMA poised to be 4th regulator approving Boehringer’s Jascayd lung drug — BioWorld
- 12:00 PM · BioWorld12:00 PMMEK inhibitor delivers 17.3-month OS for pancreatic cancer — BioWorld
- 11:28 AM · Endpoints News11:28 AMFDA grants Daiichi Sankyo and AstraZeneca’s Datroway a key breast cancer approval — Endpoints News
- 9:00 AM · Endpoints News9:00 AMNovartis says Avidity's science could apply beyond muscular dystrophies — Endpoints News
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMNew PARP1/2-tankyrase inhibitor bests first-gen PARP inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMAVB-406: AAV-miRNA targeting MAPT in Alzheimer’s disease — BioWorld
- 9:00 AM · BioWorld9:00 AMTREM2 agonists detailed in Pfizer patent — BioWorld
- 9:00 AM · BioWorld9:00 AMDual-targeting, rapamycin-enhanced CAR T for multiple myeloma — BioWorld
- 9:00 AM · BioWorld9:00 AMAsgard’s AT-108 shows promise as immunotherapeutic — BioWorld
- 9:00 AM · BioWorld9:00 AMHenlius gains Australian trial clearance for HLX-3902 — BioWorld
- 9:00 AM · BioWorld9:00 AMScribe’s STX-1150 for hypercholesterolemia cleared for clinic — BioWorld
- 9:00 AM · BioWorld9:00 AMSangamo presents primate data for prion suppressor ST-506 — BioWorld
- 9:00 AM · BioWorld9:00 AMHanmi discloses new YAP1/TEAD interaction inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMIgnis Therapeutics synthesizes new muscarinic M4 receptor PAMs — BioWorld
- 9:00 AM · BioWorld9:00 AMSelection Therapeutics identifies new Kv1.3 blockers — BioWorld
- 8:50 AM · Pharmaceutical Technology8:50 AMCVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati — Pharmaceutical Technology
- 8:27 AM · SCMP — Tech8:27 AMFrance to invest €1.5 billion in quantum computing, advanced microchips — SCMP — Tech
- 7:00 AM · Endpoints News7:00 AMAmgen CFO to follow David Reese into retirement; Josh Smiley is out at Zai Lab — Endpoints News
- 7:00 AM · STAT News
- 6:19 AM · Pharmaceutical Technology6:19 AMGilead Sciences acquires Tubulis for $5bn — Pharmaceutical Technology
- 5:07 AM · Pharmaceutical Technology5:07 AMConcept Life Sciences and OpenBench partner on drug discovery services — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMHaemaLogiX launches Phase I multiple myeloma trial — Drug Discovery World
- 4:30 AM · STAT News
- 4:00 AM · Drug Discovery World4:00 AMCompany shows ‘new therapeutic modality’ at ASGCT 2026 — Drug Discovery World
- 2:01 AM · Bloomberg — Technology2:01 AMInsilico on Applying AI to Transform Drug Discovery — Bloomberg — Technology
- 12:00 AM · FT — Pharmaceuticals12:00 AMGenerics drugmaker Sandoz calls for EU to probe alleged China dumping — FT — Pharmaceuticals
May 21, 2026
- 7:39 PM · STAT News
- 5:00 PM · Endpoints News5:00 PM#ASCO26: Key head and neck cancer readouts from J&J, Corbus, Summit, Akero and Bicara — Endpoints News
- 5:00 PM · Endpoints News5:00 PM#ASCO26: New data released for VEGF bispecifics from BioNTech-BMS, Pfizer-3SBio — Endpoints News
- 12:00 PM · BioWorld12:00 PMTennor’s $80M Hong Kong IPO to fund antibacterial drug pipeline — BioWorld
- 12:00 PM · BioWorld12:00 PMInfex has positive phase IIa data in bronchiectasis; preps for next trial — BioWorld
- 12:00 PM · BioWorld12:00 PMApellis soars on Biogen deal as biopharma index trails the market — BioWorld
- 12:00 PM · BioWorld12:00 PMAnother Triumph: Lilly’s triple G agonist scores in obesity — BioWorld
- 11:51 AM · BioPharma Dive11:51 AMRA Capital banks $75M for a biotech SPAC — BioPharma Dive
- 11:39 AM · Endpoints News11:39 AMChina’s drugmakers to take the stage at #ASCO26 — Endpoints News
- 11:33 AM · Pharmaceutical Technology11:33 AMGilead teams up with WHO again to eliminate parasitic tropical disease — Pharmaceutical Technology
- 10:31 AM · Endpoints News10:31 AMBioMarin to seek further approval of Voxzogo in form of short stature — Endpoints News
- 10:22 AM · Endpoints News10:22 AMIncyte signs AI deals with Genesis Molecular AI, Edison Scientific — Endpoints News
- 10:00 AM · Pharmaceutical Executive10:00 AM<![CDATA[Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report ]]> — Pharmaceutical Executive
- 9:02 AM · Endpoints News9:02 AMBMS eyes new campus in Texas; Novartis looks to evict tenant at Slovenian campus — Endpoints News
- 9:00 AM · BioPharma Dive9:00 AMIn Alzheimer’s, Bristol Myers sees big promise beyond amyloid — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMRecludix presents STAT1/3 inhibitors for dermatological diseases — BioWorld
- 9:00 AM · BioWorld9:00 AMGertrude Biomedical discovers new SOX8 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMRPT-E-037 shows promise as PDAC therapeutic — BioWorld
- 9:00 AM · BioWorld9:00 AMAevisbio patents new cereblon-targeting compounds — BioWorld
- 9:00 AM · BioWorld9:00 AMGertrude Biomedical discovers new SOX18 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMHansoh identifies new PI3Kα mutant inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMFDA clears Qihan Biotech’s CAR T therapy QT-019C for clinic — BioWorld
- 9:00 AM · BioWorld9:00 AMNampt activators disclosed in Nanjing Reju Therapeutics patent — BioWorld
- 9:00 AM · BioWorld9:00 AMNextgen Bioscience reports new S1P1 and S1P4 receptor antagonists — BioWorld
- 9:00 AM · BioWorld9:00 AMCereno Scientific to study CS-585 for antiphospholipid syndrome — BioWorld
- 9:00 AM · BioWorld9:00 AMIchnos Glenmark Innovation unveils ISB-2301 for solid tumors — BioWorld
- 7:39 AM · Drug Discovery World7:39 AMUK introduces framework for advanced therapy trials — Drug Discovery World
- 6:45 AM · NYT — Health6:45 AMExperimental Drug Yields Dramatic Weight Loss — NYT — Health
- 6:04 AM · Pharmaceutical Technology6:04 AMFUJIFILM opens new iPSC facility in Madison, US — Pharmaceutical Technology
- 5:30 AM · Pharmaceutical Technology5:30 AMATS 2026: Long-term data show durable benefit of Trikafta for cystic fibrosis — Pharmaceutical Technology
- 5:18 AM · Pharmaceutical Technology5:18 AMBMS and Anthropic collaborate for Claude implementation — Pharmaceutical Technology
- 4:30 AM · STAT News
- 2:27 AM · Bloomberg — Technology2:27 AMFormer Google Deepmind Researcher on New AI Startup — Bloomberg — Technology
- 12:00 AM · TechCrunch12:00 AMImperagen raises £5 million to use quantum physics, AI on enzyme engineering — TechCrunch